Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BLX ?6.5 WB, SLActive? 10mm, RXD: medical device reports filed with FDA

2,514 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

2,514
device reports naming the brand
0% of all MAUDE reports · about 347 a year
401
reports, 12 months to August 2026
434 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,514 reports that name the brand "BLX ?6.5 WB, SLActive? 10mm, RXD" (endosseous dental implant), received between April 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

401 reports arrived in the 12 months to August 2026, close to the 434 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (45.1%), loss of osseointegration (18.5%) and difficult to insert (3.6%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

04895Sep 2021: 18Oct 2021: 30Nov 2021: 41Dec 2021: 342022Jan 2022: 25Feb 2022: 17Mar 2022: 24Apr 2022: 51May 2022: 50Jun 2022: 30Jul 2022: 11Aug 2022: 22Sep 2022: 13Oct 2022: 51Nov 2022: 42Dec 2022: 452023Jan 2023: 24Feb 2023: 37Mar 2023: 22Apr 2023: 45May 2023: 27Jun 2023: 42Jul 2023: 41Aug 2023: 41Sep 2023: 29Oct 2023: 38Nov 2023: 35Dec 2023: 242024Jan 2024: 23Feb 2024: 24Mar 2024: 32Apr 2024: 57May 2024: 35Jun 2024: 36Jul 2024: 33Aug 2024: 48Sep 2024: 38Oct 2024: 50Nov 2024: 43Dec 2024: 332025Jan 2025: 45Feb 2025: 25Mar 2025: 18Apr 2025: 16May 2025: 0Jun 2025: 95Jul 2025: 37Aug 2025: 34Sep 2025: 24Oct 2025: 46Nov 2025: 36Dec 2025: 322026Jan 2026: 27Feb 2026: 26Mar 2026: 39Apr 2026: 39May 2026: 39Jun 2026: 26Jul 2026: 30Aug 2026: 37

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

02264522019: 4520192020: 21820202021: 34220212022: 38120222023: 40520232024: 45220242025: 40820252026: 2632026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,514
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report62.6%1,574
Voluntary report0%0
User facility report0%0
Distributor report37.4%940
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,13445.1%62.8%
Loss of osseointegration46618.5%22.4%
Difficult to insertthe device was hard to insert903.6%0.4%
Separation failure180.7%0.1%
Fracturea broken bone60.2%1.6%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis71028.2%
Painpain, site not specified35914.3%
Tissue damage1526%
Inflammationinflammation1194.7%
Swelling/ edema652.6%
Hyperresponsive to stimuli622.5%
Hemorrhage/blood loss/bleeding512%
Abscessa collection of pus331.3%
Hypersensitivity/allergic reaction261%
Sinus perforation241%
Failure of implant220.9%
Numbnessnumbness150.6%
Fistula120.5%
Inadequate osseointegration100.4%
Swellingswelling90.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBLX ?6.5 WB, SLActive? 10mm, RXDProduct code DZEAll MAUDE reports
Reports2,5143,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer62.6%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BLX ?6.5 WB, SLActive? 10mm, RXD reports

How many FDA reports name BLX ?6.5 WB, SLActive? 10mm, RXD?

2,514 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 401 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (45.1%), loss of osseointegration (18.5%), difficult to insert (3.6%), separation failure (0.7%) and fracture (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (62.6%) and distributor reports (37.4%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BLX ?6.5 WB, SLActive? 10mm, RXD was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.